This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's Small-Cap Winners & Losers

Small-cap stocks along with the major indices generally turned negative in the afternoon to erase early gains, and among the biggest decliners was Exact Sciences (EXAS - Get Report).

Shares plummeted 24.3% after the Food and Drug Administration told the Marlborough, Mass., company that its DNA technology for colorectal cancer screening, PreGen-Plus, is a medical device that needs premarket regulatory approval. Shares were down $1.46 to $4.56.

Spectrum Brands (SPC) sank 15.9% to $4.08 after the Atlanta-based maker of Rayovac batteries and other products postponed its sale of what it had called in August an "attractive strategic asset." The company cited "recent challenging conditions in the credit markets."

Massachusetts semiconductor equipment maker Axcelis Technologies (ACLS - Get Report) dropped as well, after saying it will probably take a third-quarter loss of 8 cents a share, including a 5-cent goodwill-impairment charge related to ceasing future product development in rapid thermal processing and curing. Previous guidance called for a 2-cent profit.

Revenue is also now pegged "slightly below" the previous range of $110 million to $120 million. Analysts polled by Thomson Financial are looking for a 3 cent per-share profit, excluding special items, on $115.7 million in revenue. Shares were off 24 cents, or 4.9%, at $4.70.

The Russell 2000 and the S&P SmallCap 600, which track both Spectrum and Axcelis, recently fell 0.3% to 821.79 and 0.1% to 428.48, respectively.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACLS $2.72 0.00%
CNTF $0.53 0.00%
EXAS $18.12 0.00%
FTEK $1.90 0.00%
AAPL $110.38 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs